By Ethan Covey
Originally published by our sister publication, Infectious Disease Special Edition
The risk for myocarditis after receiving one of the messenger RNA (mRNA) COVID-19 vaccines is low, yet was higher than expected, according to a new study of passive surveillance reporting in the United States.
Rates of myocarditis were highest among male adolescents and male young adults after a second vaccine dose (JAMA 2022;327[4]:331-340).
“This risk should be considered within the context of